| Literature DB >> 33583934 |
Nguyen Van Tien1, Kokichi Arisawa1, Hirokazu Uemura1,2, Nahomi Imaeda3, Chiho Goto4, Sakurako Katsuura-Kamano1.
Abstract
BACKGROUNDS: The fatty liver index (FLI) is a good non-invasive approach for fatty liver disease diagnosis. The objective of this study was to examine the associations of nutrient patterns with non-alcoholic fatty liver disease (NAFLD) in a Japanese population.Entities:
Keywords: cross-sectional study; factor analysis; fatty liver index; nutrient patterns
Mesh:
Substances:
Year: 2021 PMID: 33583934 PMCID: PMC9263617 DOI: 10.2188/jea.JE20200447
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.809
Figure 1. A flowchart showing the process of selecting study subjects. J-MICC, Japan Multi-Institutional Collaborative Cohort; NAFLD, non-alcoholic fatty liver disease.
Background characteristics of the study subjects according to Fatty Liver Index (FLI) category
| Characteristicsa | FLI <60 | FLI ≥60 | |
| ( | ( | ||
| Age, years | 49 (41, 57) | 47.5 (40, 57) | 0.34 |
| Sex | <0.0001 | ||
| Male | 662 (46.2) | 127 (81.4) | |
| Female | 770 (53.8) | 29 (18.6) | |
| Smoking status | <0.0001 | ||
| Current | 225 (15.7) | 47 (30.1) | |
| Stopped | 266 (18.6) | 53 (34.0) | |
| Never | 941 (65.7) | 56 (35.9) | |
| Alcohol status | 0.41 | ||
| Current | 684 (47.8) | 83 (53.2) | |
| Stopped | 25 (1.8) | 3 (1.9) | |
| Never | 723 (50.5) | 70 (44.9) | |
| Research group | 0.02 | ||
| Occupation | 316 (22.1) | 33 (21.2) | |
| Posting | 680 (47.5) | 91 (58.3) | |
| Health Check-up | 436 (30.5) | 32 (20.5) | |
| Alcohol intake, g/dayc | 0.0 (0, 8.0) | 1.2 (0, 9.9) | 0.07 |
| Exercise during leisure time, MET-hours/week | 3.875 (0.425, 15.75) | 2.55 (0.425, 8.725) | 0.02 |
| Body mass index, kg/m2 | 22.3 (20.5, 24.3) | 28.4 (26.1, 30.8) | <0.0001 |
| Waist circumference, cm | 79.5 (72, 85) | 95 (90, 101) | <0.0001 |
| Aspartate aminotransferase, IU/L | 21 (18, 24) | 28 (23, 36) | <0.0001 |
| Alanine aminotransferase, IU/L | 17 (13, 24) | 39 (28, 54) | <0.0001 |
| Total cholesterol, mg/dL | 208.5 (185, 232) | 218 (195, 240) | 0.0005 |
| Triglycerides, mg/dL | 81 (58, 114) | 183 (137, 264.5) | <0.0001 |
| High density lipoprotein-cholesterol, mg/dL | 60 (51, 70) | 47 (42, 53) | <0.0001 |
| γ-Glutamyl transpeptidase, IU/L | 21 (15, 31) | 51.5 (35, 84) | <0.0001 |
|
| |||
| Nutritional intake | |||
| Energy intake, kcal/day | 1,619 (1,452, 1,836) | 1,780 (1,547, 2,007) | <0.0001 |
| Protein, g/day | 50.2 (44.3, 56.8) | 53.2 (45.3, 59.7) | 0.02 |
| Monounsaturated fatty acids, g/day | 15.6 (13.4, 18.4) | 16.2 (13.1, 19.9) | 0.60 |
| Carbohydrate, g/day | 231.3 (197.5, 272.1) | 259.3 (217.9, 307.9) | <0.0001 |
| Soluble dietary fiber, g/day | 1.7 (1.4, 2.1) | 1.5 (1.2, 1.8) | <0.0001 |
| Insoluble dietary fiber, g/day | 6.9 (6.0, 8.4) | 6.2 (5.4, 6.9) | <0.0001 |
| Saturated fatty acids, g/day | 10.7 (9.1, 12.5) | 10.1 (8.5, 11.9) | 0.004 |
| n-3 polyunsaturated fatty acids, mg/day | 2,084 (1,776, 2,426) | 2,128 (1,765, 2,567) | 0.76 |
| n-6 polyunsaturated fatty acids, mg/day | 10,389 (8,700, 12,249) | 10,357 (8,603, 12,794) | 0.96 |
| Calcium, mg/day | 466 (381, 567) | 423 (344, 513) | <0.0001 |
| Sodium, mg/day | 1,565 (1,314, 1,826) | 1,539 (1,279, 1,877) | 0.87 |
| Potassium, mg/day | 2,024 (1,773, 2,291) | 1,900 (1,670, 2,198) | 0.001 |
| Iron, mg/day | 6.0 (5.0, 7.2) | 5.7 (4.7, 6.8) | 0.007 |
| Cholesterol, mg/day | 228 (182, 282) | 228 (178, 286) | 0.88 |
| Retinol equivalent, g/day | 701 (541, 991) | 558 (506, 955) | <0.0001 |
| Carotene, µg/day | 2,717 (2,114, 3,504) | 2,114 (1,913, 2,717) | <0.0001 |
| Vitamin D, µg/day | 4.9 (4.4, 7.4) | 4.9 (4.2, 7.3) | 0.23 |
| Vitamin E, mg/day | 7.6 (6.6, 9.1) | 7.7 (6.3, 8.7) | 0.10 |
| Vitamin B1, mg/day | 0.62 (0.58, 0.68) | 0.63 (0.58, 0.70) | 0.17 |
| Vitamin B2, mg/day | 0.96 (0.81, 1.13) | 0.88 (0.73, 1.11) | 0.003 |
| Vitamin C, mg/day | 83.2 (65.0, 108.1) | 71.3 (53.6, 92.5) | <0.0001 |
| Folate, µg/day | 283 (234, 355) | 255 (209, 314) | <0.0001 |
|
| |||
| Nutrient pattern scoresd | |||
| Factor 1 | 0.03 (0.03) | −0.33 (0.08) | <0.0001 |
| Factor 2 | −0.01 (0.03) | 0.11 (0.08) | 0.16 |
| Factor 3 | 0.01 (0.03) | −0.10 (0.08) | 0.19 |
| Factor 4 | −0.01 (0.03) | 0.08 (0.08) | 0.28 |
MET, metabolic equivalent.
aMedian (25%, 75%) or number of subjects (%).
bWilcoxon’s rank sum test or chi-square test.
cParticipants who drank alcohol above the diagnostic criteria for non-alcoholic fatty liver disease (male >30 g/day; female >20 g/day) were excluded.
dThe least square means adjusted for sex and standard error.
Factor loading matrix for selected nutrient patterns
| Nutrients | Factor 1 | Factor 2 | Factor 3 | Factor 4 |
| Folate | 0.91 | 0.15 | 0.11 | 0.10 |
| Carotene | 0.86 | 0.22 | 0.08 | 0.08 |
| Insoluble dietary fiber | 0.82 | 0.21 | 0.18 | 0.22 |
| Vitamin C | 0.79 | 0.11 | 0.13 | 0.15 |
| Iron | 0.74 | 0.13 | 0.13 | 0.45 |
| Retinol equivalent | 0.73 | 0.19 | 0.12 | 0.06 |
| Soluble dietary fiber | 0.72 | 0.16 | 0.16 | 0.41 |
| Potassium | 0.70 | 0.11 | 0.33 | 0.21 |
| Monounsaturated fatty acids | 0.14 | 0.94 | 0.19 | 0.03 |
| n-3 polyunsaturated fatty acids | 0.21 | 0.87 | 0.09 | 0.22 |
| n-6 polyunsaturated fatty acids | 0.20 | 0.86 | 0.09 | 0.17 |
| Vitamin E | 0.50 | 0.82 | 0.12 | 0.06 |
| Vitamin B1 | 0.05 | 0.49 | 0.33 | 0.40 |
| Cholesterol | 0.13 | 0.36 | 0.31 | 0.35 |
| Saturated fatty acids | 0.12 | 0.20 | 0.92 | 0.05 |
| Calcium | 0.34 | −0.05 | 0.78 | 0.22 |
| Vitamin B2 | 0.42 | 0.06 | 0.75 | 0.23 |
| Carbohydrate | −0.00 | −0.34 | −0.80 | 0.01 |
| Sodium | 0.26 | 0.07 | 0.04 | 0.78 |
| Protein | 0.19 | 0.33 | 0.51 | 0.65 |
| Vitamin D | 0.38 | 0.20 | 0.08 | 0.57 |
|
| ||||
| Variance | 5.9 | 4.0 | 3.4 | 2.3 |
| Cumulatve variance explained (%) | 28.0 | 46.8 | 63.2 | 74.3 |
Associations of four factor scores with high Fatty Liver Index (FLI)
| FLI ≥60 | Q1 | Q2 | Q3 | Q4 | |
| OR | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
| Factor 1 | |||||
| Number of cases (%) | 66 (16.6) | 41 (10.3) | 31 (7.8) | 18 (4.5) | |
| Model 1a | 1.00 | 0.66 (0.43–1.01) | 0.53 (0.33–0.84) | 0.36 (0.20–0.63) | 0.0002 |
| Model 2b | 1.00 | 0.70 (0.45–1.08) | 0.55 (0.34–0.89) | 0.41 (0.22–0.74) | 0.001 |
|
| |||||
| Factor 2 | |||||
| Number of cases (%) | 35 (8.8) | 39 (9.8) | 33 (8.3) | 49 (12.3) | |
| Model 1 | 1.00 | 1.31 (0.80–2.15) | 1.18 (0.71–1.98) | 1.70 (1.05–2.77) | 0.05 |
| Model 2 | 1.00 | 1.27 (0.77–2.10) | 1.17 (0.69–1.98) | 1.63 (1.00–2.69) | 0.07 |
|
| |||||
| Factor 3 | |||||
| Number of cases (%) | 56 (14.1) | 42 (10.6) | 25 (6.3) | 33 (8.3) | |
| Model 1 | 1.00 | 0.80 (0.51–1.24) | 0.51 (0.31–0.84) | 0.80 (0.49–1.28) | 0.11 |
| Model 2 | 1.00 | 0.83 (0.52–1.29) | 0.54 (0.32–0.90) | 0.86 (0.53–1.40) | 0.22 |
|
| |||||
| Factor 4 | |||||
| Number of cases (%) | 36 (9.1) | 40 (10.1) | 36 (9.1) | 44 (11.1) | |
| Model 1 | 1.00 | 1.16 (0.72–1.89) | 1.07 (0.65–1.75) | 1.39 (0.86–2.25) | 0.24 |
| Model 2 | 1.00 | 1.17 (0.71–1.91) | 1.02 (0.62–1.70) | 1.42 (0.87–2.32) | 0.24 |
CI, confidence interval; OR, odds ratio; Q, quartile.
aAdjusted for sex, age, and research group.
bAdditionally adjusted for smoking, amount of ethanol intake, total energy intake, and physical activity level.
Associations of four factor scores with each Fatty Liver Index component
| Q1 | Q2 | Q3 | Q4 | ||
| OR | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
| Body mass index ≥25 kg/m2 | |||||
| Factor 1 | |||||
| Number of cases (%) | 127 (32.0) | 108 (27.2) | 92 (23.2) | 62 (15.6) | |
| Model 2a | 1.00 | 0.92 (0.66–1.26) | 0.72 (0.52–1.01) | 0.48 (0.33–0.71) | 0.0002 |
| Factor 2 | |||||
| Number of cases (%) | 88 (22.2) | 105 (26.5) | 82 (20.7) | 114 (28.7) | |
| Model 2 | 1.00 | 1.45 (1.03–2.04) | 1.10 (0.77–1.57) | 1.64 (1.17–2.32) | 0.03 |
| Factor 3 | |||||
| Number of cases (%) | 118 (29.7) | 108 (27.2) | 83 (20.9) | 80 (20.2) | |
| Model 2 | 1.00 | 0.98 (0.71–1.36) | 0.75 (0.53–1.05) | 0.77 (0.54–1.09) | 0.06 |
| Factor 4 | |||||
| Number of cases (%) | 96 (24.2) | 99 (24.9) | 101 (25.4) | 93 (23.4) | |
| Model 2 | 1.00 | 1.05 (0.75–1.47) | 1.09 (0.78–1.52) | 0.99 (0.70–1.39) | 0.97 |
|
| |||||
| Triglycerides ≥150 mg/dL | |||||
| Factor 1 | |||||
| Number of cases (%) | 84 (21.2) | 64 (16.1) | 69 (17.4) | 53 (13.4) | |
| Model 2 | 1.00 | 0.83 (0.57–1.21) | 1.00 (0.68–1.47) | 0.89 (0.58–1.38) | 0.82 |
| Factor 2 | |||||
| Number of cases (%) | 81 (20.4) | 67 (16.9) | 66 (16.6) | 56 (14.1) | |
| Model 2 | 1.00 | 0.90 (0.61–1.31) | 1.00 (0.68–1.46) | 0.73 (0.49–1.09) | 0.20 |
| Factor 3 | |||||
| Number of cases (%) | 84 (21.2) | 68 (17.1) | 61 (15.4) | 57 (14.4) | |
| Model 2 | 1.00 | 0.90 (0.62–1.31) | 0.89 (0.60–1.30) | 0.95 (0.64–1.41) | 0.74 |
| Factor 4 | |||||
| Number of cases (%) | 62 (15.6) | 72 (18.1) | 70 (17.6) | 66 (16.6) | |
| Model 2 | 1.00 | 1.26 (0.86–1.86) | 1.19 (0.81–1.77) | 1.13 (0.76–1.68) | 0.63 |
|
| |||||
| Waist circumference (male ≥90 cm, female ≥80 cm) | |||||
| Factor 1 | |||||
| Number of cases (%) | 120 (30.2) | 111 (28.0) | 115 (29.0) | 110 (27.7) | |
| Model 2 | 1.00 | 0.81 (0.59–1.12) | 0.79 (0.57–1.10) | 0.63 (0.44–0.90) | 0.02 |
| Factor 2 | |||||
| Number of cases (%) | 104 (26.2) | 105 (26.5) | 115 (29.0) | 132 (33.3) | |
| Model 2 | 1.00 | 1.06 (0.77–1.47) | 1.21 (0.88–1.68) | 1.61 (1.16–2.23) | 0.003 |
| Factor 3 | |||||
| Number of cases (%) | 127 (32.0) | 110 (27.7) | 114 (28.7) | 105 (26.5) | |
| Model 2 | 1.00 | 0.81 (0.59–1.12) | 0.85 (0.62–1.17) | 0.69 (0.50–0.96) | 0.04 |
| Factor 4 | |||||
| Number of cases (%) | 99 (24.9) | 104 (26.2) | 131 (33.0) | 122 (30.7) | |
| Model 2 | 1.00 | 1.09 (0.79–1.52) | 1.43 (1.04–1.96) | 1.28 (0.93–1.77) | 0.05 |
|
| |||||
| γ-Glutamyl transpeptidase (male ≥85 IU/L, female ≥38 IU/L) | |||||
| Factor 1 | |||||
| Number of cases (%) | 34 (8.6) | 37 (9.3) | 43 (10.8) | 37 (9.3) | |
| Model 2 | 1.00 | 1.04 (0.63–1.72) | 1.16 (0.71–1.91) | 0.91 (0.53–1.58) | 0.85 |
| Factor 2 | |||||
| Number of cases (%) | 32 (8.1) | 39 (9.8) | 46 (11.6) | 34 (8.6) | |
| Model 2 | 1.00 | 1.34 (0.82–2.21) | 1.64 (1.01–2.68) | 1.20 (0.71–2.03) | 0.36 |
| Factor 3 | |||||
| Number of cases (%) | 44 (11.1) | 38 (9.6) | 33 (8.3) | 36 (9.1) | |
| Model 2 | 1.00 | 0.86 (0.54–1.37) | 0.70 (0.43–1.14) | 0.79 (0.48–1.28) | 0.24 |
| Factor 4 | |||||
| Number of cases (%) | 32 (8.1) | 32 (8.1) | 44 (11.1) | 43 (10.8) | |
| Model 2 | 1.00 | 1.01 (0.60–1.68) | 1.38 (0.86–2.26) | 1.28 (0.78–2.09) | 0.19 |
CI, confidence interval; OR, odds ratio; Q, quartile.
aAdjusted for sex, age, research group, smoking, amount of ethanol intake, total energy intake, and physical activity level.